| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Community-Acquired Infections | 18 | 2020 | 2328 | 1.99 | Why? |
| Fluoroquinolones | 4 | 2019 | 235 | 1.54 | Why? |
| Fosfomycin | 2 | 2019 | 48 | 1.50 | Why? |
| Chlorhexidine | 3 | 2018 | 176 | 1.25 | Why? |
| Pneumococcal Vaccines | 8 | 2019 | 571 | 1.16 | Why? |
| Escherichia coli Infections | 5 | 2019 | 348 | 1.12 | Why? |
| Anti-Bacterial Agents | 28 | 2020 | 10083 | 1.12 | Why? |
| Urinary Tract Infections | 3 | 2019 | 534 | 1.11 | Why? |
| Netherlands | 32 | 2021 | 3533 | 1.06 | Why? |
| Bacteremia | 5 | 2018 | 1372 | 1.00 | Why? |
| Pneumonia, Bacterial | 6 | 2020 | 843 | 0.99 | Why? |
| Gastrointestinal Tract | 4 | 2019 | 1113 | 0.94 | Why? |
| Cross Infection | 16 | 2021 | 8675 | 0.82 | Why? |
| Surgical Wound Infection | 4 | 2018 | 501 | 0.79 | Why? |
| Gram-Negative Bacteria | 4 | 2018 | 473 | 0.78 | Why? |
| Macrolides | 4 | 2019 | 369 | 0.78 | Why? |
| Poisons | 1 | 2019 | 26 | 0.77 | Why? |
| beta-Lactams | 3 | 2019 | 210 | 0.77 | Why? |
| Gram-Negative Bacterial Infections | 3 | 2018 | 398 | 0.75 | Why? |
| Escherichia coli | 8 | 2019 | 1547 | 0.75 | Why? |
| Bacterial Translocation | 1 | 2018 | 39 | 0.71 | Why? |
| Pneumonia, Pneumococcal | 5 | 2019 | 251 | 0.69 | Why? |
| Ciprofloxacin | 1 | 2018 | 130 | 0.69 | Why? |
| beta-Lactamases | 9 | 2019 | 759 | 0.68 | Why? |
| Enterococcus faecium | 4 | 2018 | 95 | 0.64 | Why? |
| Vancomycin Resistance | 2 | 2018 | 55 | 0.64 | Why? |
| Sepsis | 13 | 2019 | 3517 | 0.64 | Why? |
| Vaccine Potency | 2 | 2017 | 339 | 0.63 | Why? |
| Opportunistic Infections | 2 | 2020 | 602 | 0.62 | Why? |
| Pneumococcal Infections | 5 | 2019 | 562 | 0.61 | Why? |
| Automation | 1 | 2018 | 429 | 0.59 | Why? |
| Enterobacteriaceae Infections | 5 | 2019 | 529 | 0.59 | Why? |
| Drug Resistance, Bacterial | 8 | 2019 | 1414 | 0.58 | Why? |
| Pneumonia | 9 | 2020 | 5652 | 0.58 | Why? |
| Mouthwashes | 1 | 2018 | 432 | 0.53 | Why? |
| Baths | 1 | 2013 | 62 | 0.51 | Why? |
| Antibiotic Prophylaxis | 3 | 2018 | 399 | 0.48 | Why? |
| Heart Diseases | 3 | 2019 | 3503 | 0.48 | Why? |
| Vaccines, Conjugate | 4 | 2019 | 328 | 0.47 | Why? |
| Enterobacteriaceae | 5 | 2019 | 395 | 0.46 | Why? |
| Enterococcus | 1 | 2012 | 73 | 0.45 | Why? |
| Drug Resistance, Multiple, Bacterial | 5 | 2018 | 1115 | 0.45 | Why? |
| Immunomodulation | 1 | 2020 | 1472 | 0.43 | Why? |
| Decontamination | 2 | 2019 | 1196 | 0.41 | Why? |
| Ventilation | 1 | 2017 | 1145 | 0.39 | Why? |
| Gram-Positive Bacterial Infections | 2 | 2017 | 323 | 0.38 | Why? |
| Shock, Septic | 5 | 2018 | 1313 | 0.36 | Why? |
| Anti-Infective Agents | 2 | 2018 | 1766 | 0.36 | Why? |
| Respiratory System | 2 | 2018 | 3213 | 0.34 | Why? |
| Double-Blind Method | 8 | 2018 | 5988 | 0.34 | Why? |
| Intraabdominal Infections | 2 | 2019 | 90 | 0.34 | Why? |
| Anti-Infective Agents, Local | 1 | 2013 | 520 | 0.32 | Why? |
| Colistin | 3 | 2018 | 217 | 0.31 | Why? |
| Intensive Care Units | 19 | 2021 | 29594 | 0.31 | Why? |
| BCG Vaccine | 3 | 2020 | 1137 | 0.30 | Why? |
| Randomized Controlled Trials as Topic | 7 | 2020 | 10649 | 0.30 | Why? |
| Disinfection | 1 | 2018 | 2912 | 0.29 | Why? |
| Epidemiological Monitoring | 1 | 2018 | 3493 | 0.28 | Why? |
| Streptococcus pneumoniae | 3 | 2019 | 827 | 0.28 | Why? |
| Diabetes Complications | 1 | 2017 | 2358 | 0.28 | Why? |
| Rectum | 2 | 2018 | 495 | 0.27 | Why? |
| Bacterial Infections | 3 | 2020 | 2229 | 0.26 | Why? |
| Gentamicins | 3 | 2018 | 76 | 0.25 | Why? |
| Blood Glucose | 1 | 2017 | 3642 | 0.25 | Why? |
| Aged | 45 | 2021 | 215776 | 0.25 | Why? |
| Influenza Vaccines | 1 | 2018 | 2941 | 0.23 | Why? |
| DNA, Bacterial | 4 | 2018 | 835 | 0.23 | Why? |
| Carrier State | 3 | 2018 | 2100 | 0.23 | Why? |
| Immunity, Innate | 1 | 2020 | 6570 | 0.23 | Why? |
| Candida | 2 | 2018 | 425 | 0.22 | Why? |
| Fever | 1 | 2018 | 7795 | 0.22 | Why? |
| Hospitals | 3 | 2018 | 11793 | 0.22 | Why? |
| Humans | 87 | 2021 | 930598 | 0.21 | Why? |
| Nitrofurantoin | 1 | 2019 | 14 | 0.21 | Why? |
| Bacteria | 4 | 2018 | 1897 | 0.21 | Why? |
| Vaccination | 5 | 2020 | 19050 | 0.21 | Why? |
| Contact Tracing | 1 | 2020 | 8448 | 0.20 | Why? |
| Electronic Health Records | 3 | 2018 | 3492 | 0.20 | Why? |
| Critical Illness | 12 | 2021 | 17281 | 0.20 | Why? |
| Cystitis | 1 | 2019 | 45 | 0.20 | Why? |
| Escherichia coli Proteins | 2 | 2018 | 168 | 0.20 | Why? |
| Middle Aged | 40 | 2021 | 270681 | 0.19 | Why? |
| Female | 50 | 2021 | 380317 | 0.19 | Why? |
| Esophagectomy | 1 | 2019 | 76 | 0.19 | Why? |
| Drug Resistance, Microbial | 1 | 2003 | 419 | 0.19 | Why? |
| Kidney Transplantation | 1 | 2019 | 5397 | 0.19 | Why? |
| Genomic Islands | 1 | 2018 | 26 | 0.19 | Why? |
| Respiration, Artificial | 5 | 2021 | 22116 | 0.19 | Why? |
| Pneumonia, Ventilator-Associated | 2 | 2019 | 861 | 0.19 | Why? |
| Male | 49 | 2021 | 367725 | 0.18 | Why? |
| Tobramycin | 1 | 2018 | 18 | 0.18 | Why? |
| Equivalence Trials as Topic | 1 | 2018 | 242 | 0.18 | Why? |
| Microbial Sensitivity Tests | 8 | 2018 | 2886 | 0.18 | Why? |
| Heparin | 2 | 2021 | 2600 | 0.18 | Why? |
| Absenteeism | 1 | 2020 | 287 | 0.18 | Why? |
| Histidine Kinase | 1 | 2017 | 3 | 0.18 | Why? |
| Bacitracin | 1 | 2017 | 17 | 0.18 | Why? |
| Feces | 5 | 2017 | 4235 | 0.18 | Why? |
| beta-Lactam Resistance | 1 | 2019 | 150 | 0.18 | Why? |
| Pneumonia, Staphylococcal | 1 | 2017 | 38 | 0.18 | Why? |
| Teichoic Acids | 1 | 2017 | 4 | 0.17 | Why? |
| Tetracycline | 1 | 2017 | 33 | 0.17 | Why? |
| Reimbursement, Incentive | 1 | 2018 | 70 | 0.17 | Why? |
| Critical Care | 7 | 2019 | 14081 | 0.17 | Why? |
| Hospitalization | 15 | 2021 | 54280 | 0.17 | Why? |
| Biosynthetic Pathways | 1 | 2017 | 97 | 0.17 | Why? |
| Carbapenems | 2 | 2018 | 343 | 0.17 | Why? |
| Food Microbiology | 1 | 2018 | 114 | 0.17 | Why? |
| Influenza, Human | 2 | 2020 | 10779 | 0.17 | Why? |
| Staphylococcus aureus | 3 | 2018 | 844 | 0.16 | Why? |
| Polymerase Chain Reaction | 5 | 2018 | 6740 | 0.16 | Why? |
| Bacterial Proteins | 4 | 2019 | 1318 | 0.16 | Why? |
| Gram-Positive Bacteria | 1 | 2018 | 230 | 0.16 | Why? |
| Fasciitis, Necrotizing | 1 | 2017 | 56 | 0.16 | Why? |
| Vancomycin-Resistant Enterococci | 1 | 2017 | 104 | 0.16 | Why? |
| Q Fever | 1 | 2018 | 130 | 0.16 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.16 | Why? |
| Herpesviridae | 1 | 2017 | 100 | 0.16 | Why? |
| Biological Assay | 1 | 2019 | 367 | 0.16 | Why? |
| Cellulitis | 1 | 2017 | 119 | 0.15 | Why? |
| Carbapenem-Resistant Enterobacteriaceae | 1 | 2018 | 214 | 0.15 | Why? |
| Dust | 1 | 2017 | 178 | 0.15 | Why? |
| Diagnostic Tests, Routine | 2 | 2017 | 2643 | 0.15 | Why? |
| Placebos | 1 | 2018 | 629 | 0.15 | Why? |
| Serogroup | 4 | 2019 | 510 | 0.15 | Why? |
| Genetic Fitness | 1 | 2017 | 339 | 0.15 | Why? |
| Environment, Controlled | 1 | 2017 | 129 | 0.15 | Why? |
| Prospective Studies | 17 | 2018 | 43301 | 0.15 | Why? |
| Anticoagulants | 3 | 2021 | 9563 | 0.15 | Why? |
| Remission Induction | 1 | 2019 | 950 | 0.15 | Why? |
| Models, Theoretical | 5 | 2020 | 6659 | 0.15 | Why? |
| Drug Therapy | 1 | 2018 | 280 | 0.15 | Why? |
| Herpesviridae Infections | 1 | 2017 | 172 | 0.14 | Why? |
| Diabetes Mellitus | 1 | 2017 | 8207 | 0.14 | Why? |
| Cardiovascular Surgical Procedures | 1 | 2018 | 281 | 0.14 | Why? |
| Administration, Intravenous | 1 | 2018 | 1115 | 0.14 | Why? |
| Abdomen | 1 | 2018 | 424 | 0.14 | Why? |
| Thrombosis | 3 | 2021 | 7504 | 0.14 | Why? |
| Lymphoma, Non-Hodgkin | 1 | 2018 | 403 | 0.14 | Why? |
| Aged, 80 and over | 14 | 2021 | 88759 | 0.14 | Why? |
| Patients' Rooms | 1 | 2019 | 675 | 0.14 | Why? |
| Administration, Oral | 2 | 2018 | 2340 | 0.14 | Why? |
| DNA-Binding Proteins | 1 | 2017 | 469 | 0.13 | Why? |
| Genetic Variation | 2 | 2018 | 3919 | 0.13 | Why? |
| Regression Analysis | 2 | 2019 | 2484 | 0.13 | Why? |
| Immunization | 3 | 2017 | 2019 | 0.13 | Why? |
| Drug Synergism | 1 | 2017 | 833 | 0.13 | Why? |
| Calcium Channel Blockers | 1 | 2017 | 367 | 0.13 | Why? |
| Hospital Costs | 1 | 2016 | 274 | 0.13 | Why? |
| Digestive System | 1 | 2013 | 110 | 0.12 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.12 | Why? |
| Meat | 1 | 2016 | 380 | 0.12 | Why? |
| Receptors, Interleukin-6 | 1 | 2021 | 1383 | 0.12 | Why? |
| Pseudomonas Infections | 1 | 2017 | 425 | 0.12 | Why? |
| Environmental Microbiology | 1 | 2018 | 575 | 0.12 | Why? |
| Gastroenteritis | 1 | 2017 | 489 | 0.12 | Why? |
| Colon | 1 | 2018 | 669 | 0.12 | Why? |
| Lipopolysaccharides | 1 | 2017 | 848 | 0.12 | Why? |
| Amphotericin B | 1 | 2013 | 256 | 0.12 | Why? |
| Recurrence | 2 | 2019 | 3675 | 0.12 | Why? |
| Cohort Studies | 11 | 2019 | 36005 | 0.11 | Why? |
| Public Health Practice | 1 | 2020 | 945 | 0.11 | Why? |
| Multicenter Studies as Topic | 4 | 2020 | 2437 | 0.11 | Why? |
| Arthroplasty, Replacement, Knee | 1 | 2017 | 363 | 0.11 | Why? |
| Arthroplasty, Replacement, Hip | 1 | 2017 | 403 | 0.11 | Why? |
| Bias | 2 | 2020 | 1109 | 0.11 | Why? |
| Time Factors | 6 | 2020 | 31397 | 0.11 | Why? |
| Cost-Benefit Analysis | 2 | 2018 | 2259 | 0.11 | Why? |
| Respiratory Tract Infections | 2 | 2018 | 6817 | 0.11 | Why? |
| Interleukin-8 | 1 | 2017 | 964 | 0.11 | Why? |
| Infection Control | 4 | 2019 | 23131 | 0.11 | Why? |
| Digestive System Surgical Procedures | 1 | 2018 | 677 | 0.11 | Why? |
| Cross-Over Studies | 3 | 2019 | 867 | 0.10 | Why? |
| Oropharynx | 1 | 2018 | 1581 | 0.10 | Why? |
| Hydrocortisone | 1 | 2020 | 1790 | 0.10 | Why? |
| Interleukin-10 | 1 | 2017 | 1409 | 0.10 | Why? |
| Chickens | 1 | 2016 | 1010 | 0.10 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2018 | 1439 | 0.10 | Why? |
| Hospitals, University | 2 | 2019 | 4173 | 0.10 | Why? |
| Viremia | 1 | 2017 | 1020 | 0.10 | Why? |
| Adult | 23 | 2021 | 244371 | 0.10 | Why? |
| Clostridium Infections | 1 | 2017 | 595 | 0.10 | Why? |
| Candidiasis | 1 | 2013 | 334 | 0.10 | Why? |
| Interleukin-6 | 2 | 2017 | 7522 | 0.09 | Why? |
| Metagenome | 1 | 2011 | 268 | 0.09 | Why? |
| Treatment Outcome | 7 | 2020 | 51732 | 0.09 | Why? |
| Bacterial Typing Techniques | 2 | 2020 | 273 | 0.09 | Why? |
| Staphylococcal Infections | 1 | 2018 | 1099 | 0.09 | Why? |
| Hospital Mortality | 7 | 2021 | 22087 | 0.09 | Why? |
| Health Care Costs | 1 | 2016 | 1007 | 0.09 | Why? |
| Virus Diseases | 1 | 2005 | 3779 | 0.09 | Why? |
| Lymphopenia | 1 | 2020 | 2669 | 0.09 | Why? |
| Biomarkers | 7 | 2019 | 23361 | 0.09 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.08 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.08 | Why? |
| Length of Stay | 4 | 2017 | 11042 | 0.08 | Why? |
| Case-Control Studies | 4 | 2019 | 17671 | 0.08 | Why? |
| International Cooperation | 1 | 2020 | 3436 | 0.08 | Why? |
| Respiratory Insufficiency | 2 | 2018 | 7301 | 0.08 | Why? |
| Disinfectants | 1 | 2017 | 1077 | 0.08 | Why? |
| Multilocus Sequence Typing | 2 | 2018 | 264 | 0.08 | Why? |
| Drug Therapy, Combination | 2 | 2017 | 7268 | 0.08 | Why? |
| Health Status | 2 | 2017 | 3259 | 0.08 | Why? |
| Ritonavir | 1 | 2021 | 4212 | 0.08 | Why? |
| Phenotype | 1 | 2017 | 4037 | 0.08 | Why? |
| Inflammation Mediators | 1 | 2017 | 2654 | 0.08 | Why? |
| Residence Characteristics | 1 | 2017 | 1927 | 0.08 | Why? |
| Patient Isolation | 1 | 2019 | 3182 | 0.07 | Why? |
| Quality of Life | 2 | 2017 | 9820 | 0.07 | Why? |
| Predictive Value of Tests | 2 | 2017 | 9537 | 0.07 | Why? |
| Genomics | 1 | 2017 | 3118 | 0.07 | Why? |
| Cephalosporins | 2 | 2018 | 250 | 0.07 | Why? |
| Retrospective Studies | 8 | 2020 | 105322 | 0.07 | Why? |
| Metagenomics | 1 | 2011 | 823 | 0.07 | Why? |
| APACHE | 2 | 2017 | 682 | 0.07 | Why? |
| Guideline Adherence | 1 | 2017 | 2309 | 0.07 | Why? |
| Mobile Applications | 1 | 2020 | 3032 | 0.07 | Why? |
| Swine | 3 | 2018 | 3352 | 0.07 | Why? |
| Animals | 7 | 2020 | 78931 | 0.07 | Why? |
| Europe | 5 | 2018 | 12702 | 0.07 | Why? |
| Gastrointestinal Microbiome | 1 | 2017 | 1961 | 0.07 | Why? |
| Mortality | 2 | 2017 | 7132 | 0.06 | Why? |
| Young Adult | 6 | 2021 | 93724 | 0.06 | Why? |
| Disease Outbreaks | 1 | 2012 | 27595 | 0.06 | Why? |
| Clinical Trials as Topic | 2 | 2020 | 7330 | 0.06 | Why? |
| Population Surveillance | 2 | 2017 | 4967 | 0.06 | Why? |
| Risk Factors | 8 | 2020 | 71621 | 0.06 | Why? |
| Antifungal Agents | 1 | 2013 | 1828 | 0.06 | Why? |
| Logistic Models | 3 | 2021 | 9089 | 0.06 | Why? |
| Immunocompromised Host | 1 | 2019 | 5150 | 0.06 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.06 | Why? |
| Venous Thromboembolism | 1 | 2020 | 4273 | 0.06 | Why? |
| Multivariate Analysis | 2 | 2020 | 5440 | 0.06 | Why? |
| Bayes Theorem | 2 | 2021 | 3237 | 0.06 | Why? |
| Anti-Inflammatory Agents | 1 | 2020 | 6153 | 0.06 | Why? |
| RNA, Ribosomal, 16S | 2 | 2017 | 793 | 0.05 | Why? |
| Coinfection | 2 | 2020 | 6820 | 0.05 | Why? |
| Postoperative Complications | 1 | 2019 | 5861 | 0.05 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.05 | Why? |
| Algorithms | 1 | 2017 | 7346 | 0.05 | Why? |
| Age Factors | 5 | 2021 | 21039 | 0.05 | Why? |
| Drug Combinations | 2 | 2021 | 3852 | 0.05 | Why? |
| Air Pollutants | 1 | 2017 | 3110 | 0.05 | Why? |
| Electrophoresis, Gel, Pulsed-Field | 1 | 2018 | 78 | 0.05 | Why? |
| Odds Ratio | 2 | 2021 | 5861 | 0.05 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 9335 | 0.05 | Why? |
| Staphylococcal Vaccines | 1 | 2018 | 13 | 0.05 | Why? |
| Hemorrhage | 2 | 2021 | 3013 | 0.05 | Why? |
| Virus Replication | 1 | 2020 | 14331 | 0.05 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2018 | 11367 | 0.05 | Why? |
| Occupational Exposure | 1 | 2017 | 4742 | 0.04 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2020 | 8843 | 0.04 | Why? |
| Blood Culture | 1 | 2020 | 308 | 0.04 | Why? |
| Holidays | 1 | 2021 | 311 | 0.04 | Why? |
| Haemophilus influenzae | 1 | 2018 | 196 | 0.04 | Why? |
| Delayed-Action Preparations | 1 | 2019 | 291 | 0.04 | Why? |
| Coxiella burnetii | 1 | 2018 | 120 | 0.04 | Why? |
| Early Termination of Clinical Trials | 1 | 2020 | 1256 | 0.04 | Why? |
| Aminoglycosides | 1 | 2017 | 94 | 0.04 | Why? |
| Evidence-Based Medicine | 2 | 2020 | 3228 | 0.04 | Why? |
| Zebrafish | 1 | 2017 | 181 | 0.04 | Why? |
| Multigene Family | 1 | 2018 | 377 | 0.04 | Why? |
| Visual Analog Scale | 1 | 2017 | 151 | 0.04 | Why? |
| Random Allocation | 1 | 2019 | 773 | 0.04 | Why? |
| Blood | 1 | 2017 | 274 | 0.04 | Why? |
| Nasopharynx | 2 | 2018 | 10224 | 0.04 | Why? |
| Protein C | 1 | 2017 | 141 | 0.04 | Why? |
| Incidence | 4 | 2020 | 25622 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Poultry | 1 | 2018 | 437 | 0.04 | Why? |
| Prevalence | 4 | 2019 | 25773 | 0.04 | Why? |
| Genetic Markers | 1 | 2017 | 318 | 0.04 | Why? |
| Gene Expression Profiling | 2 | 2017 | 3788 | 0.04 | Why? |
| Comorbidity | 2 | 2017 | 34796 | 0.04 | Why? |
| Severity of Illness Index | 3 | 2020 | 48226 | 0.04 | Why? |
| Markov Chains | 1 | 2017 | 502 | 0.04 | Why? |
| Farms | 1 | 2017 | 269 | 0.04 | Why? |
| Tertiary Care Centers | 3 | 2017 | 8248 | 0.04 | Why? |
| Research Design | 1 | 2012 | 5830 | 0.04 | Why? |
| Treatment Failure | 1 | 2021 | 2106 | 0.04 | Why? |
| Birds | 1 | 2018 | 412 | 0.04 | Why? |
| Endpoint Determination | 1 | 2017 | 344 | 0.04 | Why? |
| Vancomycin | 1 | 2018 | 328 | 0.04 | Why? |
| Antigens, Bacterial | 1 | 2017 | 330 | 0.03 | Why? |
| Colectomy | 1 | 2018 | 327 | 0.03 | Why? |
| Risk Assessment | 4 | 2020 | 25439 | 0.03 | Why? |
| Genome, Bacterial | 1 | 2017 | 446 | 0.03 | Why? |
| Quality-Adjusted Life Years | 1 | 2017 | 511 | 0.03 | Why? |
| Adolescent | 3 | 2021 | 86841 | 0.03 | Why? |
| Biofilms | 1 | 2017 | 304 | 0.03 | Why? |
| Farmers | 1 | 2017 | 280 | 0.03 | Why? |
| Endemic Diseases | 1 | 2018 | 480 | 0.03 | Why? |
| Antibodies, Bacterial | 1 | 2017 | 510 | 0.03 | Why? |
| Pain Measurement | 1 | 2017 | 533 | 0.03 | Why? |
| Antithrombins | 1 | 2017 | 353 | 0.03 | Why? |
| Health Personnel | 2 | 2021 | 29646 | 0.03 | Why? |
| Epitope Mapping | 1 | 2018 | 1240 | 0.03 | Why? |
| Intestines | 1 | 2019 | 817 | 0.03 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.03 | Why? |
| Cardiovascular Physiological Phenomena | 1 | 2013 | 70 | 0.03 | Why? |
| Shock | 1 | 2020 | 1868 | 0.03 | Why? |
| Klebsiella Infections | 1 | 2018 | 466 | 0.03 | Why? |
| Hand | 1 | 2017 | 449 | 0.03 | Why? |
| Cooperative Behavior | 1 | 2020 | 1216 | 0.03 | Why? |
| Pseudomonas aeruginosa | 1 | 2017 | 652 | 0.03 | Why? |
| Plasmids | 1 | 2016 | 840 | 0.03 | Why? |
| Sputum | 1 | 2020 | 1720 | 0.03 | Why? |
| Viruses | 1 | 2005 | 2238 | 0.03 | Why? |
| Heparin, Low-Molecular-Weight | 1 | 2021 | 1731 | 0.03 | Why? |
| Longitudinal Studies | 2 | 2018 | 9893 | 0.03 | Why? |
| Healthy Volunteers | 1 | 2017 | 1444 | 0.03 | Why? |
| Genetic Heterogeneity | 1 | 2011 | 77 | 0.03 | Why? |
| Sensitivity and Specificity | 2 | 2018 | 22971 | 0.03 | Why? |
| Organ Dysfunction Scores | 1 | 2017 | 1475 | 0.03 | Why? |
| Lung | 1 | 2020 | 31049 | 0.03 | Why? |
| Heptavalent Pneumococcal Conjugate Vaccine | 1 | 2011 | 64 | 0.03 | Why? |
| Reproducibility of Results | 2 | 2018 | 11304 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2018 | 2324 | 0.03 | Why? |
| Patients | 1 | 2018 | 1167 | 0.03 | Why? |
| Dose-Response Relationship, Drug | 1 | 2019 | 3776 | 0.03 | Why? |
| Genome-Wide Association Study | 1 | 2017 | 1648 | 0.03 | Why? |
| Up-Regulation | 1 | 2018 | 2249 | 0.02 | Why? |
| Observational Studies as Topic | 1 | 2017 | 1887 | 0.02 | Why? |
| Individuality | 1 | 2011 | 142 | 0.02 | Why? |
| Nebulizers and Vaporizers | 1 | 2013 | 497 | 0.02 | Why? |
| Troponin I | 1 | 2018 | 1298 | 0.02 | Why? |
| Basic Reproduction Number | 1 | 2021 | 2676 | 0.02 | Why? |
| Socioeconomic Factors | 2 | 2017 | 8495 | 0.02 | Why? |
| Phylogeny | 2 | 2018 | 13341 | 0.02 | Why? |
| Microcirculation | 1 | 2013 | 447 | 0.02 | Why? |
| Sequence Analysis, RNA | 1 | 2017 | 2290 | 0.02 | Why? |
| Propensity Score | 1 | 2017 | 2690 | 0.02 | Why? |
| Immunologic Memory | 1 | 2020 | 3362 | 0.02 | Why? |
| Survival Analysis | 1 | 2021 | 7592 | 0.02 | Why? |
| Pilot Projects | 1 | 2019 | 5182 | 0.02 | Why? |
| Administration, Inhalation | 1 | 2013 | 1647 | 0.02 | Why? |
| Endothelial Cells | 1 | 2017 | 2048 | 0.02 | Why? |
| Hand Disinfection | 1 | 2017 | 1671 | 0.02 | Why? |
| Ventilator Weaning | 1 | 2012 | 536 | 0.02 | Why? |
| Multiple Organ Failure | 1 | 2017 | 1724 | 0.02 | Why? |
| Lopinavir | 1 | 2021 | 4308 | 0.02 | Why? |
| Point-of-Care Systems | 1 | 2020 | 2955 | 0.02 | Why? |
| Genotype | 1 | 2018 | 4697 | 0.02 | Why? |
| MicroRNAs | 1 | 2019 | 1787 | 0.02 | Why? |
| Patient Selection | 1 | 2020 | 4560 | 0.02 | Why? |
| Epitopes | 1 | 2018 | 4113 | 0.02 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3633 | 0.02 | Why? |
| Risk | 1 | 2018 | 5288 | 0.02 | Why? |
| Diarrhea | 1 | 2017 | 2743 | 0.02 | Why? |
| Prognosis | 2 | 2020 | 32490 | 0.02 | Why? |
| England | 1 | 2017 | 5116 | 0.02 | Why? |
| Schools | 1 | 2021 | 4187 | 0.02 | Why? |
| Cytokines | 2 | 2017 | 15010 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2021 | 10017 | 0.02 | Why? |
| Acute Disease | 1 | 2018 | 6029 | 0.02 | Why? |
| Consensus | 1 | 2019 | 6345 | 0.02 | Why? |
| Transcriptome | 1 | 2018 | 3466 | 0.02 | Why? |
| Environmental Monitoring | 1 | 2017 | 3143 | 0.02 | Why? |
| Public Health Surveillance | 1 | 2018 | 3129 | 0.02 | Why? |
| Hemodynamics | 1 | 2013 | 1562 | 0.02 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2017 | 3607 | 0.02 | Why? |
| Infant | 2 | 2021 | 30274 | 0.02 | Why? |
| Models, Biological | 1 | 2021 | 4907 | 0.02 | Why? |
| Models, Statistical | 1 | 2021 | 5312 | 0.02 | Why? |
| Adrenal Cortex Hormones | 1 | 2020 | 6537 | 0.02 | Why? |
| Cause of Death | 1 | 2017 | 4823 | 0.02 | Why? |
| Child, Preschool | 2 | 2021 | 36283 | 0.01 | Why? |
| Cluster Analysis | 1 | 2011 | 3001 | 0.01 | Why? |
| Cross-Sectional Studies | 2 | 2021 | 53120 | 0.01 | Why? |
| Primary Health Care | 1 | 2019 | 4839 | 0.01 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.01 | Why? |
| Sex Factors | 1 | 2017 | 11014 | 0.01 | Why? |
| Spain | 1 | 2018 | 15545 | 0.01 | Why? |
| Blood Coagulation | 1 | 2013 | 2768 | 0.01 | Why? |
| Infant, Newborn | 1 | 2021 | 23105 | 0.01 | Why? |
| Surveys and Questionnaires | 2 | 2017 | 43792 | 0.01 | Why? |
| Noninvasive Ventilation | 1 | 2012 | 2329 | 0.01 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2021 | 9706 | 0.01 | Why? |
| Seasons | 1 | 2011 | 4071 | 0.01 | Why? |
| Antiviral Agents | 2 | 2021 | 41703 | 0.01 | Why? |
| Hydroxychloroquine | 1 | 2021 | 12447 | 0.01 | Why? |
| Pregnancy | 1 | 2019 | 23879 | 0.01 | Why? |
| Pediatrics | 1 | 2012 | 2969 | 0.01 | Why? |
| Disease Transmission, Infectious | 1 | 2018 | 9044 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2017 | 21571 | 0.01 | Why? |
| Extracorporeal Membrane Oxygenation | 1 | 2012 | 5002 | 0.01 | Why? |
| Child | 1 | 2021 | 70012 | 0.01 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.01 | Why? |